theophylline has been researched along with 2-hexynyladenosine-5'-n-ethylcarboxamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arslan, G; Dionisotti, S; Fredholm, BB; Kull, B; Ongini, E; Zocchi, C | 1 |
| Baraldi, PG; Benini, A; Borea, PA; Cattabriga, E; Gessi, S; Klotz, KN; Lennan, SM; Leung, E; Merighi, S; Tabrizi, MA; Varani, K; Vincenzi, F | 1 |
2 other study(ies) available for theophylline and 2-hexynyladenosine-5'-n-ethylcarboxamide
| Article | Year |
|---|---|
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles | 1997 |
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Molecular Structure; Protein Binding; Receptor, Adenosine A2B; Recombinant Proteins | 2005 |